Vaccine Center News | NYU Langone Health

Skip to Main Content
Vaccine Center Vaccine Center News

Vaccine Center News

Stay up to date on news happening at NYU Langone’s Vaccine Center and around the world.

News About the Vaccine Center

Launched in 2018, the Vaccine Center is growing, with new faculty and programs coming on board. Learn more about how our researchers are pursuing exciting projects that could change the landscape of healthcare.

Curing the Unknown: A Panel Discussion About HIV Infection and AIDS

Sponsored by NYU Langone’s Vaccine Center and the Department of Medicine’s Division of Infectious Diseases and Immunology, this panel discussion focuses on the impact of the HIV infection and AIDS pandemic as it unfolded in New York City and at NYU Langone in the 1980s and 1990s. Physicians and scientists who were there then share their stories and discuss how they continue to fight for a world without HIV infection and AIDS.

Panelists include Lawrence K. Altman, MD, William Borkowsky, MD, Demetre Daskalakis, MD, MPH, Michael Marmor, PhD, Mark J. Mulligan, MD, FIDSA, David M. Oshinsky, PhD, Douglas Dieterich, MD, Michael Simberkoff, MD, Alvin E. Friedman-Kien, MD, Robert S. Holzman, MD, Kenneth B. Hymes, MD, Fred T. Valentine, MD, and Susan Zolla-Pazner, PhD.

The event takes place on Tuesday, November 19, 2019, from 4:00–6:00PM in NYU Langone’s Farkas Auditorium, located at 550 First Avenue in Manhattan. A reception will follow.

Mark J. Mulligan, MD, Delivers Keynote Address at NYU School of Medicine’s White Coat Ceremony

In his remarks, Dr. Mulligan congratulated the 103 students who entered the class of 2023 and shared that medical school had a profound impact on his career.

NYU Langone’s Vaccine Center Focuses on New Vaccines for Influenza, Malaria, Tuberculosis, HIV/AIDS, and Cancer

The Vaccine Center’s director, Mark J. Mulligan, MD, discusses the center’s plan to pursue a range of innovative treatments through basic research and clinical trials.

Vaccine Center Receives an Empire Clinical Research Investigator Program Award

The Vaccine Center received a 2019 Empire Clinical Research Investigator Program Award from the New York State Department of Health. This prestigious award recognizes institutions that are advancing biomedical research through the training of physicians in clinical research.

At the Vaccine Center, we will use this resource to establish a formal training program in vaccine sciences to provide a cadre of investigators with the skills they need to translate research findings into improved health.

Vaccine Center Welcomes Inaugural Director Mark J. Mulligan, MD

Renowned infectious disease expert Mark J. Mulligan, MD, joins NYU Langone as the inaugural director of the Vaccine Center. Dr. Mulligan is well known for his interdisciplinary research focused on identifying vaccine candidates and testing their efficacy in clinical trials. He is also working to develop treatments to combat the growing epidemic of antibiotic-resistant bacteria.

Vaccine-Related News

Vaccines have the potential to prevent or treat a wide range of infectious and noninfectious diseases. Researchers and public health officials all over the globe are working to translate scientific findings into new treatments while also educating communities about the facts of inoculation.

NYU Langone Issues Guidelines to Help New Yorkers Respond to Coronavirus

NYU Langone infectious disease experts Michael S. Phillips, MD, and Jennifer L. Lighter, MD, discuss what the public needs to know about the 2019 novel coronavirus and when it’s appropriate to seek care for a respiratory illness.

Novel Coronavirus Detected in the United States

As U.S. health officials confirm the first cases of 2019 novel coronavirus disease in this country, Mark J. Mulligan, MD, Director of NYU Langone Vaccine Center, discusses risks for contracting the disease and precautions for preventing it’s spread, as well as tips for concerned parents. Despite the risks, Dr. Mulligan cautions the public not to overreact.
As coronavirus continues to spread in China, where the virus first emerged, U.S. health officials are advising people to avoid travel to the country. As the public reacts the news of the disease, sales of clinical face masks are on the rise. But infectious disease expert Vanessa N. Raabe, MD, explains why the masks may be less effective at curbing the spread of coronavirus than other methods. To put the likelihood of becoming ill from the disease context, Dr. Lighter explains that the flu remains a greater risk to the health of Americans.

Rise in STD Cases Alarms Health Officials

Declines in condom use and more prevalent STD testing may be behind an increase in the incidence of three STDs—gonorrhea, syphilis, and chlamydia—for the fifth consecutive year, according to a report from the U.S. Centers for Disease Control.

The Biggest Cause of the Measles Crisis is Vaccine Hesitancy, Not Avoidance

In an opinion piece, Jennifer L. Lighter, MD, an assistant professor in the Department of Pediatrics at NYU Langone and the hospital’s epidemiologist, argues that deviations from the Centers for Disease Control and Prevention vaccination schedule results in a more vulnerable population and led to the recent measles outbreak.

How the Anti-Vaccine Movement was Decades in the Making

The World Health Organization lists vaccine hesitancy as one of the top threats to global health, and the anti-vaccine momentum that has been building for years shows no signs of slowing down.

Health Officials Say Measles Outbreak Has Ended in New York City

On September 3, 2019, public health officials declared that the measles outbreak in New York City, which saw 634 cases of the disease, is over.

Public Health Officials Confront Dangerous Ideas About Measles

A cavalier attitude toward measles contributed to the recent outbreak and is proving to be a stubborn adversary for public health officials trying to enforce vaccinations.

The Centers for Disease Control and Prevention Recommend Getting Flu Shots by the End of October

Vanessa N. Raabe, MD, a Vaccine Center faculty member, explains that this year’s flu shot is updated to be most effective against the strains experts predict will cause illness this flu season.

Max D. Cooper, MD, and Jacques Miller, PhD, Receive Lasker Awards for Advances in Modern Immunology

Dr. Cooper and Dr. Miller were honored with the Albert Lasker Basic Medical Research Award for identifying B cells and T cells, two distinct classes of white blood cells that help the body fight off germs.

Yes, You Can Get the Flu in August

Although the flu season officially starts in October, Vaccine Center faculty member Vanessa N. Raabe, MD, says that it’s possible to contract the virus any time of year.

HIV Can Hide in Spinal Fluid Even After Long Term Treatment

New research shows that even after a decade of treatment, some people who have HIV infection still have HIV cells in their cerebrospinal fluid, which can increase their risk for cognitive problems.

First Universal Flu Vaccine Currently in Clinical Trials

The National Institutes of Health (NIH) aims to develop a new vaccine that could provide long-term immunity to all types of the flu.

Why Medieval Diseases Are Hitting Modern Cities Hard

Cities across the United States are seeing outbreaks of “medieval” diseases, in part because homelessness and other social inequities put certain populations at risk.

Cases of Flesh-Eating Bacteria Are on the Rise

Infections caused by flesh-eating bacteria are rising on the east coast, and the effects can potentially be life-threatening. Scott A. Weisenberg, MD, medical director of NYU Langone’s Infectious Disease Associates, answers questions about the potentially-deadly bacteria and how minimize the risk of exposure.